A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
Nearly all of Latin America was excluded from the deal, sparking concern the world is missing a critical opportunity to stop ...
Lenacapavir injection lowers HIV risk by 96%
Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
Labroots15h
Twice Yearly Injection 96% Reduces HIV Infection Risk by 96%
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...
HIV prophylactic lenacapavir — very safe and very expensive
Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to ...
Daily5h
Clinical trial reveals twice-yearly injection to be 96% effective in HIV prevention
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...
Interesting Engineering on MSN2d
From chronic to curable: Twice-yearly shot shows near-total HIV eradication
Conducted by Emory University and Grady Health System and funded by Gilead, the trial showed that Lenacapavir offers a ...
Six-Month HIV Prevention Shot Achieves 99% Efficacy in Major Study
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
clinicaltrialsarena6d
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial
Gilead Sciences has announced the outcomes from the Phase III PURPOSE 2 trial evaluating lenacapavir for HIV prevention.
fingerlakes12d
Twice-Yearly HIV Shot Could Revolutionize Prevention, But Access Remains Uneven
A new HIV prevention drug, lenacapavir, has shown 100% effectiveness in women and near-perfect results in men during trials.
'Huge relief' as new drug found to effectively prevent HIV infection
A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published ...